Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Minerva Pediatrica|July 1, 1992
[Ewing's sarcoma of the bone. Anatomoclinical study of 424 cases]G Bacci, S Ferrari, P Rosito, et al.
American Journal of Diseases of Children (1960)|November 1, 1988
Differential effects of 18- and 24-Gy cranial irradiation on growth rate and growth hormone release in children with prolonged survival after acute lymphocytic leukemiaA Cicognani, E Cacciari, V Vecchi, et al.
La Chirurgia Degli Organi Di Movimento|January 1, 1990
Vertebral histiocytosisS Boriani, D Donati, P Picci, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1996
Response of previously untreated metastatic rhabdomyosarcoma to combination chemotherapy with carboplatin, epirubicin and vincristineE Frascella, K Pritchard-Jones, S Modak, et al.
Oncology Reports|May 19, 2011
Long-term follow-up for patients with Ewing's sarcoma of bone treated with adjuvant and neoadjuvant chemotherapyG Bacci, S Ferrari, E Barbieri, et al.
Italian Journal of Orthopaedics and Traumatology|December 1, 1991
Non-metastatic Ewing's sarcoma: results in 98 patients treated with neoadjuvant chemotherapyG Bacci, S Ferrari, M Avella, et al.
Minerva Pediatrica|November 1, 1995
[Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)]G Bacci, S Ferrari, P Rosito, et al.
Minerva Chirurgica|April 1, 1997
[The type of local treatment conditions the prognosis in patients with nonmetastatic Ewing's sarcoma of the extremities treated with adjuvant chemotherapy]G Bacci, S Ferrari, P Rosito, et al.
Cancer|August 1, 1980
Smooth-muscle antibodies in children with neuroblastomaD Zauli, F B Bianchi, T Gardelli, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1988
Neoadjuvant chemotherapy for osteosarcoma of the extremities. Good response of the primary tumor after preoperative chemotherapy with high-dose methotrexate followed by cisplatinum and adriamycin. Preliminary resultsG Bacci, M Avella, A Brach Del Prevert, et al.
Pageof 6